PrimeRFP SCOUT · Federal Contract Recompete Brief

FA301623F0292Fentanyl norfentanyl immunoassy reagent — Alere San Diego, Inc

Alere San Diego, Inc holds $42.8M across 9,132 federal awards, concentrated at Department of Defense (DOD). PoP ended Sep 16, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fa3016 502 Cons Cl

Awarding office

Alere San Diego, Inc

Recipient

Sep 16, 2023

PoP end

$140K

Obligated

$140K

Potential

325413

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Alere San Diego, Inc — $90

Contract facts

Federal

Contract numberFA301623F0292

Also listed asFA3016-23-F-0292

Also listed asN6264520D5004-FA301623F0292

AgencyFa3016 502 Cons Cl

Awarding officeFa3016 502 Cons Cl

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAlere San Diego, Inc

CAGE6W6P3

UEITWMQTHHN6HM5

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVN6264520D5004

Place of performanceJBSA LACKLAND TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJun 30, 2023

PoP end (current)Sep 16, 2023

Obligated$140K

Current value$140K

Potential value$140K

FENTANYL/NORFENTANYL IMMUNOASSY REAGENT is a federal award for Fa3016 502 Cons Cl held by Alere San Diego, Inc. Estimated value $140K ($140K obligated). Current period of performance ends Sep 16, 2023. Place of performance: JBSA LACKLAND TX.

Recompete timing

Public

● Past PoP end (1070 days ago)

Current PoP ended Sep 16, 2023 (1070 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Alere San Diego, Inc — $42.8M obligated across 9,132 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($42.8M) · all agencies · Top 3 shown (3%); remaining ~97% is other agencies.

Department of Defense (DOD)$770K · 2%

Court Services and Offender Supervision Agency (CSOSA)$625K · 1%

Department of Transportation (DOT)$51K · 0%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract FA301623F0292?

FA301623F0292 (Fentanyl norfentanyl immunoassy reagent) is a Fa3016 502 Cons Cl award with a potential value of $140K, currently held by Alere San Diego, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is FA3016-23-F-0292?

FA3016-23-F-0292 is the dashed form of PIID FA301623F0292 (Fentanyl norfentanyl immunoassy reagent), held by Alere San Diego, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded FA301623F0292?

Fa3016 502 Cons Cl awarded FA301623F0292 to Alere San Diego, Inc (potential $140K).

Who is the incumbent on FA301623F0292?

Alere San Diego, Inc is the incumbent with $42.8M across 9132 related awards in SCOUT’s public footprint. The current period of performance ends Sep 16, 2023.

When does Alere San Diego, Inc’s FA301623F0292 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 16, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Aug 10, 2023